Clinical Edge Journal Scan

Dietary vitamin D intake tied to lower risk for colorectal cancer in patients at high CV risk


 

Key clinical point: A higher dietary vitamin D intake was associated with reduced risk for colorectal cancer (CRC) and colon cancer in older individuals at high cardiovascular (CV) risk.

Major finding: After excluding individuals consuming vitamin D and/or calcium medication or prescribed supplements at baseline, those in highest vs. lowest quartile of vitamin D intake had 48% (hazard ratio [HR], 0.52; 95% confidence interval [CI], 0.28-0.96) and 56% (HR, 0.41; 95% CI, 0.12-0.85) lower risk of developing CRC and colon cancer alone, respectively.

Study details: Findings are from an analysis of 7,216 men and women aged between 55 and 80 years and at high CV risk from the PREvención con DIeta MEDiterránea study.

Disclosures: Spanish Instituto de Salud Carlos III (ISCIII) is funded by FEDER and supported by the official funding agency for biomedical research of the Spanish government, ISCIII, and others . J Salas‐Salvadó declared being a member of and receiving grants/research support, honoraria, and personal fees from various sources. The other authors declared no conflicts of interest.

Source: Hernández-Alonso P et al. Eur J Nutr. 2021 May 28. doi: 10.1007/s00394-021-02585-1 .

Recommended Reading

Does surgery for colorectal liver metastases release tumor cells?
MDedge Hematology and Oncology
CRC screening guidelines: 45 is the new 50, and 85 is the new 75
MDedge Hematology and Oncology
NPs and PAs performing colonoscopies: Why not?
MDedge Hematology and Oncology
Clinical Edge Journal Scan Commentary: Colorectal Cancer July 2021
MDedge Hematology and Oncology
Continuation of screening endoscopy beyond age 75 prevents CRC incidence and death
MDedge Hematology and Oncology
Perioperative systemic therapy feasible and safe in patients with resectable colorectal peritoneal metastases
MDedge Hematology and Oncology
HLX04, an alternative biosimilar to bevacizumab for refractory/metastatic colorectal cancer
MDedge Hematology and Oncology
Cumulative social risk linked to reduced receipt of chemotherapy in patients with advanced CRC
MDedge Hematology and Oncology
Anlotinib substantially prolongs PFS in metastatic CRC
MDedge Hematology and Oncology
Obesity tied to increased risk for colorectal cancer in patients with Lynch syndrome
MDedge Hematology and Oncology